Studies using circulating CLL populations have clearly demonstrated that they can induce T cell dysfunction and, together with data from a murine model of CLL, have implicated molecules such as CD274, CD276, CTLA-4 and IL10 in this process [6, 10, 14, 33, 34]. This evidence concerns the gene CTLA4 and B-cell chronic lymphocytic leukemia.